AP [3/29] | The FDA has approved selling naloxone without a prescription, the first opioid treatment drug to be sold over the counter. It’s a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately. Cont.
SAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911 to help in better understanding the...
SAMHSA [12/18] – SAMHSA recently published five documents to promote the integration and advancement of promising practices in SUD...
NIDA [12/17] – After declining significantly during the COVID-19 pandemic, substance use among adolescents has continued to hold steady...
コメント